A sample of Australian hospitals was surveyed about their practice preferences in relation to the management of epidural analgesia for postoperative pain. Results indicated substantial variation in practice preference across institutions with respect to observation protocols, epidural analgesia duration, catheter removal where anticoagulant therapy is concurrent and management of catheter problems. Further research appears necessary to develop optimal epidural analgesia management practice.
The last decade has seen the rapid recognition of epidural analgesia as an efficacious method of acute pain management. Numerous studies have demonstrated the superiority of epidural analgesia over conventional opioid techniques [1] [2] [3] [4] . It is increasingly accepted that epidural analgesia can be safely maintained on general wards if patient selection and management is appropriate and adequately supervised, preferably by an Acute Pain Service 5, 6 . Choices in relation to various aspects of management of epidural analgesia have been less well researched and this is likely to lead to wide variation in clinical practice.
The objective of this descriptive study was to present current practice preferences in relation to postoperative management of acute pain using epidural analgesia across a spectrum of Australian hospitals.
METHOD
A questionnaire (Figure 1 ) was designed and distributed to the Pain Management departments of 35 large hospitals across Australia. Both urban and rural institutions were approached from New South Wales and the Australian Capital Territory. Only institutions based in capital cities were approached from Victoria, Queensland, Western Australia and South Australia. The survey sought information about current practice in the management of epidural analgesia. Survey question formats were twofold, firstly, direct questions regarding preference in relation to drug choice, epidural analgesia duration, epidural catheter removal and patient-controlled epidural analgesia (PCEA); and secondly, problem management scenarios were posed and the respondents' preferred approach sought.
RESULTS
Thirty-five institutions were mailed survey forms and 29 institutions responded (83%). Twenty-six of these responses (74%) were included in the analysis and three were excluded as their epidural analgesia activity was minimal or non-existent. Responses have been grouped into domains and summarized as follows 
Observation and Monitoring
All departments advocated an intensive period of observation (i.e. half hourly or hourly) for 12 to 24 hours following the commencement of epidural analgesia, where the patient was stable and local anaesthetic with opioid was used. However, after the initial intensive observation period, some disagreement among respondents was noted (Figures 2, 3, 4 and 5).
A majority favoured a second hourly observation protocol for the duration of epidural analgesia with respect to blood pressure (BP), pulse, respiratory rate, sedation and pain score monitoring ( Figure 2 ). Thirty-one per cent of respondents preferred a fourth hourly protocol for pulse and blood pressure.
Respondents were asked their views regarding the frequency of observation of the insertion site and of motor blockade. There was little agreement ( Figures  3 and 4 ). Monitoring preferences ranged from once per hour to once per 24 hours during the initial 24 hours and most departments monitored motor block much more frequently than the insertion site ( Figure  3 ). The frequency of observation appeared more consistent after the initial intense observation period, and most institutions were likely to monitor each indicator once every eight hours ( Figure 4 ).
Institutions were asked to provide details of their observational monitoring policy in relation to the special circumstances of PCEA or nurseadministered bolus dosing. Nine institutions (36%) indicated PCEA activity and 19 institutions (76%) nurse-administered dosing. Observation protocols in relation to BP, pulse, respiratory rate and sedation score are compared in Figure 5 .
There was a clear difference in observation fre- quency depending on whether the bolus was nurse-or patient-administered, with the nurse-administered method attracting a much more conservative observation protocol ( Figure 5 ). The questionnaire did not canvass how nurse-patient communication occurred when an epidural bolus was patient-administered.
Epidural Analgesia Duration
There was significant policy variation among institutions in relation to the duration of epidural analgesia, however the majority of respondents advocated either a five-day limit or no limit (subject to a continuing need for epidural analgesia and the absence of local inflammation) ( Figure 6 ).
Epidural catheter removal in patients receiving anticoagulant therapy
A majority of respondents were in agreement regarding the most appropriate practice when remov-ing a catheter from patients on subcutaneous or intravenous heparin therapy ( Figure 7 ). However, a number of institutions (17%, 15% and 18% respectively) had no policy or guideline in relation to catheter removal in conjunction with intravenous, subcutaneous or low molecular weight heparin.
Management of Problems Associated with Epidural Catheters
Preferences in relation to the management of fluid leak, dressings at the insertion site and catheter-filter disconnection are summarized in Figure 8 . It appeared that disconnection at the filter is viewed more seriously than leakage at the insertion site or dislodgement of the dressing.
Epidural Drugs in Current Use
The combination of local anaesthetic and fentanyl was the most popular and only one in four institutions reported using pethidine, and less than half morphine, as a sole agent.
Staff Communication Mechanisms
Respondents were asked to indicate whether there was any feedback mechanism in place between the anaesthetist who inserted the epidural and the clinician(s) involved in ongoing management. Twenty-two of the 25 respondents (85%) indicated that communication occurred. Two institutions reported no feedback mechanisms and a further two failed to respond to the question. Some respondents identified a formal process (e.g., formal meetings, monthly reports and individual contact systems), while others indicated that feedback was informal.
DISCUSSION
A key aim of epidural analgesia management is the early recognition of drug-related and catheter-related adverse effects and complications. The monitoring of patients is largely undertaken by nurses, however there is little published guidance in relation to frequency of observation. Are observations conducted frequently enough to ensure patient safety, or is the patient discomforted and the nurse unnecessarily occupied by overly frequent observation protocols? Our findings illustrate the varied institutional responses to this dilemma. The majority of institutions favoured second hourly vital sign and pain score monitoring after an initial period of intensive observation. However, some institutions opted for fourth hourly observations, while others used a much more conservative hourly protocol. The situation was more diverse again in relation to observing the catheter insertion site and degree of motor block. This variation may reflect the institu- tions' level of experience with epidural analgesia or their relative conservatism. Rare but potentially disastrous complications of epidural analgesia like epidural haematoma or epidural abscess may result in serious morbidity which is minimized by early detection 7, 8 . More research is needed to establish whether the frequency of monitoring has an impact on complication rates and outcomes. In view of the low complication rate, only large multicentre studies are likely to yield worthwhile results. An interesting finding is the marked difference in the frequency of observation recommended when a bolus dose is nurse-rather than patient-administered. Patient-controlled epidural analgesia has primarily been used among the young and healthy obstetric population. Patients with nurse-controlled epidural analgesia are more likely to have undergone major operations, be elderly and more susceptible to drugrelated side-effects. Does the difference in patient population explain the dissimilarity in the reported approach to observation? Another ambiguity relates to the current practice by most institutions of monitoring vital signs five minutely for a 20-minute period following a nurse-administered bolus. It is not clear whether the aim is to detect effects related to drug peak plasma levels, maximal epidural spread, motor and autonomic changes, or to detect problems related to potential hypotension or intravascular or subarachnoid injection. Epidural bupivacaine takes 30 minutes or more to reach peak plasma concentration 9 and about 25 minutes to reach maximal segmental spread 10 .
Epidural analgesia administered for acute pain is usually continued until pain can be managed with oral analgesics, and in most cases this period does not exceed a few days. However, oral analgesia may not always be feasible, for example, in the case of ileus following abdominal surgery. Does prolonged epidural catheterization increase risk of infection? Localized catheter exit infections appear to be generally of the same magnitude for epidural analgesia as for intravascular devices 11 . A prospective audit by Burstal et al reported a significant increase in epidural catheterization site inflammation when catheters were in place for four or more days 5 . Published opinions regarding the optimal duration of epidural analgesia and the risk of epidural abscess vary. Breivik 7 considered the duration of epidural catheterization was not decisive, but in a recent large prospective audit (n=17,372), Wang et al noted a longer mean catheterization time among patients with epidural abscess compared with the total epidural analgesia population 12 . In our survey, institutions varied in their views regarding maximum duration, though most respondents were inclined toward five days or longer, with corresponding regular observation of signs of infection.
In recent years, the concurrent use of anticoagulant therapy and epidural analgesia has become common. Coexisting anticoagulation presents a management dilemma at epidural catheter removal, because epidural haematomas have occurred 13, 14 . It appears wise to assume that epidural catheter removal is as traumatic as placement, so catheters should not be withdrawn in the presence of therapeutic anticoagulation 15 higher and more frequent enoxaparin dosing compared with European standards 16 . The American Society of Regional Anesthesia has recently published a symposium issue on central nerve block and anticoagulation in its journal 17 .
This survey identified variation in policies concerning leakage at the catheter insertion site, accidental site exposure and catheter-filter disconnection. Some 30 to 40% of institutions reported that they cease epidural analgesia if leakage or site exposure occurs, because they believe that infection is more likely in these situations. Catheter-filter disconnection was viewed with concern, with some 60% of institutions proceeding to epidural catheter removal. There is little evidence on which to base such decisions, although suggestions for safe reconnection of a disconnected catheter have been made 18 .
In conclusion, Australian institutions are actively using epidural analgesia and PCEA, but published information in relation to the management of these modalities is lacking. This survey found that practices vary substantially. Collaborative development of epidural analgesia management guidelines should be undertaken by Pain Management and/or Anaesthesia Departments, or interested bodies, and research is needed to evaluate the range of current practices.
